The trademark ClobaDerm was filed by Auden McKenzie (Pharma Division) Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on April 24, 2012, and received one opposition filed on June 18, 2012 by INTERNOVA OÜ on Likelihood of confusion. the opponent was represented by PATENDIBÜROO TURVAJA OÜ and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued June 18, 2012
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Requests for conversion of an EUTM application into a national trade mark application of the trademark registration was recorded on February 16, 2015.